Genomma Lab Internacional, SAB de CV (BMV:LABB), a pharmaceutical and personal care products company in Latin America, announced on Tuesday that it has filed a Notice of Rights with the Mexican Stock Exchange (Bolsa Mexicana de Valores) declaring a cash dividend of MXN0.200000 per share on its common stock, representing a total amount of MXN200,000,000.
This is unchanged from the previous quarterly dividend.
The dividend will be paid to shareholders of record at the close of business on 17 September 2024.
USANA Health Sciences acquires controlling stake in Hiya Health for USD205m
Valneva and Serum Institute of India partner to expand chikungunya vaccine access in Asia
Lilly and EVA Pharma granted regulatory approval for locally manufactured insulin in Egypt
Abbott announces dividend increase and 53 years of growth
SK bioscience begins clinical trials for mRNA Japanese encephalitis vaccine